Polymerase Chain Reaction Market: Global Industry Analysis and Forecast (2023-2029)

Polymerase Chain Reaction Market was valued at US$ 9.23 Bn. in 2022. Global Polymerase Chain Reaction Market size is expected to grow at a CAGR of 8.67% through the forecast period.
Polymerase Chain Reaction Market Overview:
Polymerase chain reaction is a laboratory technique for rapidly producing millions to billions of copies of a specific segment of DNA, which can then be studied in greater detail. PCR involves using short synthetic DNA fragments called primers to select a segment of the genome to be amplified, and then multiple rounds of DNA synthesis to amplify that segment.To know about the Research Methodology :- Request Free Sample Report

PCR is fundamental to many of the procedures used in genetic testing and research, including analysis of ancient samples of DNA and identification of infectious agents. Using PCR, copies of very small amounts of DNA sequences are exponentially amplified in a series of cycles of temperature changes. PCR is now a common and often indispensable technique used in medical laboratory research for a broad variety of applications including biomedical research and criminal forensics.

Applications of the technique include DNA cloning for sequencing, gene cloning and manipulation, gene mutagenesis; construction of DNA-based phylogenies, or functional analysis of genes diagnosis and monitoring of genetic disorders, amplification of ancient DNA analysis of genetic fingerprints for DNA profiling and detection of pathogens in nucleic acid tests for the diagnosis of infectious diseases.

The report explores the Polymerase Chain Reaction Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2022. The report investigates the Polymerase Chain Reaction Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Polymerase Chain Reaction Market's contemporary competitive scenario
Market Dynamics:
One of the most significant, powerful, and frequently utilised tools in modern biology is polymerase chain reaction. It's a molecular approach for in-vitro amplification and producing millions of copies of a DNA strand. The rise in the prevalence of infectious diseases, cancer, and genetic diseases, as well as the adoption of technologies for their diagnosis, is a major factor driving the polymerase chain reaction market expansion over the forecast period.

The market for polymerase chain reaction is being driven by an increase in the number of patients suffering from tuberculosis, herpes simplex virus, and the abrupt emergence of the COVID-19 pandemic across the globe, all of which necessitate accurate illness detection. This condition is diagnosed quickly using PCR technology.

In pharmaceutical and biotechnology research, as well as microbiological quality control, the polymerase chain reaction (PCR) has proven to be successful. In addition, PCR technology is applied in the field of genetic engineering. Regular testing of raw materials and finished products for microbial contamination is a critical practise in the pharmaceutical and biotechnology industries. Genetic engineering is the primary driver of the global polymerase chain reaction (PCR) market, and it is also used to discover genes associated with specific phenotypes, such as genetic illnesses. For quality control analysis in the pharmaceutical business, advanced analytical technologies such as polymerase chain reaction (PCR) have been widely used.

Increased R&D spending, advancements in pharmacogenomics, the trend of self-diagnosing diseases as a preventive measure, and the emergence of the digital PCR technology, which is highly beneficial in cancer diagnosis, are all expected to propel the global PCR market forward during the forecast period. Furthermore, the worldwide PCR market is expected to grow due to an increase in research and development efforts in advanced molecular biology, genetic engineering, and forensic science over the forecast period.

Furthermore, rising research and development efforts in advanced molecular biology, forensic science, need for customised medicine, and genetic engineering are expected to fuel market expansion throughout the forecast period.
Polymerase Chain Reaction Market Segment Analysis:
Based on Type

Based on the type PCR market is segmented into standard, real time and digital PCR. The real time segment is dominated in the global market share in 2022. Increasing demand owing to the COVID-19 pandemic spurred the growth in the sales of the companies. Additionally technology advances coupled with new product launch by the key players have been instrumental in the dominance of the real time devices in the global market.

Digital PCR segment is projected to register a significant CAGR during the forecast period. Introduction of new product launches by market player and shifting patient preference towards based on digital technology are factors projected to fuel the demand for this type and promote the global market growth during the forecast period.

By product analysis

Based on product analysis market is segmented into instruments and reagents and consumables. Reagents and consumables segment dominated the market owing to their high usage in assays. Increasing prevalence of infectious disease such as COVID- 19 are contributing to the growing demand for reagents and consumables across the globe.

The instrument segment is expected to grow at slower pace. Technology advanced instruments and their increasing adoption are some of the factors attributable to this growth.

By indication analysis

Based on indication market is segmented into infectious disease, oncology, genetic disorder and other. Infectious disease held the leading position in the Polymerase Chain Reaction Market. Growing prevalence of cancer in countries globally owing to the changes in lifestyle patterns is contributing to the adoption of this technology by number of hospitals and diagnostic center.
Regional Insights:
North America dominated the Polymerase Chain Reaction market due to increased awareness of PCR products, major research funding in national budgets, early availability of improved technology, and an increase in R&D efforts in the region. The market in North America is being driven by an increase in the frequency of various forms of cancer and metabolic illnesses, which necessitate better diagnosis and therapy.

The rise of the PCR market in industrialized European countries such as the United Kingdom, France, Italy, and Germany is fueled by the introduction of automated PCR instruments, as well as increased purchasing power and affordability. Furthermore, the PCR industry in Europe is fueled by less onerous regulatory clearance processes than in the United States.

Due to improved health care infrastructure, increased private and governmental investment in life science research, and technological breakthroughs in countries such as China and India, the market in Asia Pacific is expected to grow at a quick pace during the forecast period.
Polymerase Chain Reaction Market Scope: Inquire before buying



Polymerase Chain Reaction Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US$ 9.23 Bn.


Forecast Period 2023 to 2029 CAGR:
8.67%
Market Size in 2029:
US$ 16.53 Bn.


 Segments Covered:
by Type
Standard PCR
Real time PCR
Digital PCR


by product
Consumables and reagents
Instruments


by indication
Infectious diseases
Oncology
Genetic disorder
Other



Polymerase Chain Reaction Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Polymerase Chain Reaction Market Key Players are:
1. Bio-Rad Laboratories
2. Qiagen
3. Hoffmann-La Roche
4. Agilent Technologies
5. Abbott
6. Eppendorf AG
7. Sysmex Inostics
8. Thermo Fisher Scientific Inc.
9. Becton
10.Siemens healthcare
11.Danaher corporation
12.Fluidigm
13.Takara Bio
14.BioMerieux
15.BD
16.Eppendorf AG

Frequently Asked Questions:

1] What segments are covered in the Polymerase Chain Reaction Market report?
Ans. The segments covered in the market report are based on Type, by product and by indication.

2] Which region is expected to hold the highest share in the Polymerase Chain Reaction Market?
Ans. North America region is expected to hold the highest share in the Polymerase Chain Reaction Market.

3] What is the market size of the Polymerase Chain Reaction Market by 2029?
Ans. The market size of the Polymerase Chain Reaction Market by 2029 is expected to reach US$ 16.53 Bn.

4] What is the forecast period for the Polymerase Chain Reaction Market?
Ans. The forecast period for the Polymerase Chain Reaction Market is 2023-2029.

5] What was the market size of the Polymerase Chain Reaction Market in 2022?
Ans. The market size of the Polymerase Chain Reaction Market in 2022 was valued at US$ 9.23 Bn.